Issuer · CIK 0001001233
SGMO — SANGAMO THERAPEUTICS, INC
Recent filings
- May 27, 2026·Form 4·Other$284.1
SGMO/SANGAMO THERAPEUTICS, INC
Davis Gregory D · Head of Research & Technology
Mechanical filing
AI thesis skipped - May 27, 2026·Form 4·Other$334.5
SGMO/SANGAMO THERAPEUTICS, INC
Jain Nikunj · Principal Accounting Officer
Mechanical filing
AI thesis skipped - May 27, 2026·Form 4·Other$703.5
SGMO/SANGAMO THERAPEUTICS, INC
Dubois-Stringfellow Nathalie · SVP-CHIEF DEVELOPMENT OFFICER
Mechanical filing
AI thesis skipped - May 27, 2026·Form 4·Other$703.5
SGMO/SANGAMO THERAPEUTICS, INC
Willoughby Scott B. · SVP, CHIEF LEGAL OFFICER, SECY
Mechanical filing
AI thesis skipped - May 27, 2026·Form 4·Other$2.2K
SGMO/SANGAMO THERAPEUTICS, INC
Macrae Sandy · PRESIDENT, CEO AND DIRECTOR
Mechanical filing
AI thesis skipped - Apr 3, 2026·Form 4·Other—
SGMO/SANGAMO THERAPEUTICS, INC
Willoughby Scott B. · SVP, CHIEF LEGAL OFFICER, SECY
Mechanical filing
AI thesis skipped